DE3852118T2 - Protease-ähnliche zytotoxische lymphozyten-spezifische moleküle und verfahren. - Google Patents
Protease-ähnliche zytotoxische lymphozyten-spezifische moleküle und verfahren.Info
- Publication number
- DE3852118T2 DE3852118T2 DE3852118T DE3852118T DE3852118T2 DE 3852118 T2 DE3852118 T2 DE 3852118T2 DE 3852118 T DE3852118 T DE 3852118T DE 3852118 T DE3852118 T DE 3852118T DE 3852118 T2 DE3852118 T2 DE 3852118T2
- Authority
- DE
- Germany
- Prior art keywords
- protease
- specific molecules
- cytotoxic lymphocyte
- cytotoxic
- molecule
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6424—Serine endopeptidases (3.4.21)
- C12N9/6467—Granzymes, e.g. granzyme A (3.4.21.78); granzyme B (3.4.21.79)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/005—Enzyme inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/62—DNA sequences coding for fusion proteins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/142—Toxicological screening, e.g. expression profiles which identify toxicity
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Analytical Chemistry (AREA)
- Transplantation (AREA)
- Plant Pathology (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Epidemiology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US296087A | 1987-01-13 | 1987-01-13 | |
PCT/US1988/000071 WO1988005471A1 (en) | 1987-01-13 | 1988-01-13 | Cytotoxic lymphocyte-specific protease-related molecules and methods |
Publications (2)
Publication Number | Publication Date |
---|---|
DE3852118D1 DE3852118D1 (de) | 1994-12-22 |
DE3852118T2 true DE3852118T2 (de) | 1995-06-29 |
Family
ID=21703390
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE3852118T Expired - Fee Related DE3852118T2 (de) | 1987-01-13 | 1988-01-13 | Protease-ähnliche zytotoxische lymphozyten-spezifische moleküle und verfahren. |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP0300033B1 (de) |
JP (1) | JPH01502198A (de) |
AT (1) | ATE114159T1 (de) |
DE (1) | DE3852118T2 (de) |
WO (1) | WO1988005471A1 (de) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5004692A (en) * | 1987-12-15 | 1991-04-02 | Protein Design Labs, Inc. | Cloning and expression of phosopholipase C genes |
CA2074081A1 (en) * | 1990-01-19 | 1991-07-20 | Robert C. Bleackley | Cytotoxic cell-specific protease-related molecules and methods |
-
1988
- 1988-01-13 WO PCT/US1988/000071 patent/WO1988005471A1/en active IP Right Grant
- 1988-01-13 EP EP88902625A patent/EP0300033B1/de not_active Expired - Lifetime
- 1988-01-13 DE DE3852118T patent/DE3852118T2/de not_active Expired - Fee Related
- 1988-01-13 AT AT88902625T patent/ATE114159T1/de not_active IP Right Cessation
- 1988-01-13 JP JP63502609A patent/JPH01502198A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
EP0300033B1 (de) | 1994-11-17 |
JPH01502198A (ja) | 1989-08-03 |
EP0300033A4 (de) | 1990-02-05 |
DE3852118D1 (de) | 1994-12-22 |
EP0300033A1 (de) | 1989-01-25 |
WO1988005471A1 (en) | 1988-07-28 |
ATE114159T1 (de) | 1994-12-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK552684A (da) | Desulfatohirudiner samt deres fremstilling og anvendelse | |
SE8206168D0 (sv) | Preparations and process for preparation thereof | |
ES2062355T3 (es) | Composicion farmaceutica que comprende loratadina, ibuprofeno y pseudoefedrina. | |
ATE314116T1 (de) | Verwendung von roxithromycin zur herstellung eines medikaments zur verbesserung der biologischen und antiviralen aktivität von protease-inhibitoren | |
NO885109D0 (no) | Fremgangsmte og middel for forhindre blodpropp. | |
FI862756A0 (fi) | Fibroektiner. | |
DK66692A (da) | En mammal cytokin, il-11 | |
ATE126535T1 (de) | ''walk-through''-mutagenese. | |
DE3684078D1 (de) | Reinigung und aktivierung von proteinen aus unloeslichen einschlusskoerpern. | |
ES2032755T3 (es) | Medicamentos conteniendo hexadecil-fosfocolina con efecto antitumoral. | |
FI946004A (fi) | Lääketieteellisessä toimenpiteessä käytettävä trombiiniverifraktio | |
DE69131589T2 (de) | Ribosomen-inaktivierende Proteine, inaktive Vorläuferformen derselben, Verfahren zur Herstellung und eine Methode zur Nutzung | |
DK0502872T3 (da) | Fremgangsmåder og materialer til eksprimering af human plasminogenvariant | |
DE69110713D1 (de) | 7-Oxabicycloheptan-imidazol-prostaglandin-Analoge, verwendbar bei der Behandlung von thrombotischen und vasospastischen Erkrankungen. | |
EP0336779A3 (de) | Durch kovalenten Ersatz von Wasserstoffbrücken stabilisierte Polypeptide | |
IT998023B (it) | Procedimento per ridurre l4ossigeno biochimico necessario per le acque di scarico e per il ricupero delle proteine in esse contenute | |
AR004093A1 (es) | El uso de una proteina derivada de una quimioquina de mamifero y un medicamento util para movilizar celulas tronco hematopoyeticas. | |
DE3852118T2 (de) | Protease-ähnliche zytotoxische lymphozyten-spezifische moleküle und verfahren. | |
ATE49420T1 (de) | Verfahren zur reinigung von plasminogenaktivatoren (pa). | |
FI885025A0 (fi) | Koagulationshaemmande protein pp4-x, dess framstaellning och anvaendning. | |
PT83721B (pt) | Processo de preparacao de composicoes farmaceuticas a base de activadores de plasminogenio com actividade trombolitica | |
DE59107762D1 (de) | Komplexe, enthaltend S(+)-Phenyl-alkansäuren und alpha-Hydroxy-alkansäuren | |
NO920524D0 (no) | Kynurensyrederivater, deres fremstilling og farmasoeytiskeblandinger inneholdende disse | |
ATE75938T1 (de) | Enantiomere des propafenons enthaltende therapeutische mittel. | |
IT7819048A0 (it) | Procedimento ed impianto per la concentrazione di acque con elevato contenuto di sale e povere in sostanze volatili, in particolare di acque di rifiuto delle industrie. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8339 | Ceased/non-payment of the annual fee |